The Scienomics Group
Raffaele Camasta has a diverse work experience starting from an internship as an analyst at the Medical Analysis Laboratory "Prato della Valle" in 2004. Raffaele then conducted research as a graduate researcher at the University of Freiburg, specializing in the proteomics of yeast peroxisomes. Raffaele continued their research as a graduate researcher at the University of Waterloo, where they focused on mitochondrial dysfunction and its connection to secondary functions of assembly factors. During this time, they also worked as a teaching assistant, gaining experience in effectively communicating complex concepts to students. Raffaele then transitioned into medical writing roles, initially as a medical content writer at Medical News Bulletin in 2018 and later as a project manager and medical writer at SAGE Renegade. Raffaele further advanced their career as a senior medical writer at Caudex in 2021 before assuming their current role as an Assistant Medical Director at The Scienomics Group in 2022.
Raffaele Camasta completed their education in a chronological order as follows:
From 2006 to 2009, they pursued a Bachelor of Science degree in Biotechnology at the Università degli Studi di Padova.
Between 2009 and 2012, they attended the Università degli Studi di Padova again, this time for a Master of Science degree in Pharmaceutical Biotechnology.
In 2011, they had a brief stint at The University of Freiburg for their Master of Science in Pharmaceutical Biotechnology.
Finally, from 2013 to 2018, Raffaele Camasta pursued a Doctor of Philosophy (PhD) in Biology at the University of Waterloo.
This person is not in any offices
The Scienomics Group
The Scienomics Group (TSG) is a member of the Healthcare Consultancy Group (HCG), an OMNICOM Group company. For over 15 years, TSG has been an industry leader in scientific and medical strategy and communications. At TSG our passion is science. We are a powerful team of professionals, committed to partnership and united by a shared purpose of helping our clients commercialize their breakthrough therapies. By harnessing our scientific insights, creativity, and deep healthcare marketing expertise, we are able to uniquely communicate the scientific basis and clinical rationale for new therapies. To learn more about career opportunities at TSG, please visit: https://hub-hcg.icims.com/jobs/search?ss=1&searchCompany=4813 For more information, please visit us at www.tsgmeded.com